rs142598041
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001127178.3(PIGG):c.2086G>A(p.Glu696Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000123 in 1,613,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E696D) has been classified as Uncertain significance.
Frequency
Consequence
NM_001127178.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PIGG | NM_001127178.3 | c.2086G>A | p.Glu696Lys | missense_variant | 10/13 | ENST00000453061.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PIGG | ENST00000453061.7 | c.2086G>A | p.Glu696Lys | missense_variant | 10/13 | 1 | NM_001127178.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000183 AC: 46AN: 250706Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135552
GnomAD4 exome AF: 0.000120 AC: 175AN: 1461864Hom.: 0 Cov.: 30 AF XY: 0.000106 AC XY: 77AN XY: 727234
GnomAD4 genome AF: 0.000151 AC: 23AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74274
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 01, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Intellectual disability, autosomal recessive 53 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 13, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 12, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 696 of the PIGG protein (p.Glu696Lys). This variant is present in population databases (rs142598041, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with PIGG-related conditions. ClinVar contains an entry for this variant (Variation ID: 476330). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PIGG protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.2086G>A (p.E696K) alteration is located in exon 10 (coding exon 10) of the PIGG gene. This alteration results from a G to A substitution at nucleotide position 2086, causing the glutamic acid (E) at amino acid position 696 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
PIGG-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 10, 2024 | The PIGG c.2086G>A variant is predicted to result in the amino acid substitution p.Glu696Lys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.025% of alleles in individuals of Latino descent in gnomAD. A variant affecting the same amino acid (c.2088G>C; p.Glu696Asp) has been reported in the compound heterozygous state with a second variant in the gene (c.2041C>T; p.Arg681Trp) in a patient with PIGG-related neurodevelopmental disease (Tremblay-Laganiere et al. 2021. PubMed ID: 34113002). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at